US Patent Issued to Ionis Pharmaceuticals on Jan. 20 for "Methods and compositions for inhibiting PMP22 expression" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,055, issued on Jan. 20, was assigned to Ionis Pharmaceuticals Inc. (Carlsbad, Calif.).

"Methods and compositions for inhibiting PMP22 expression" was invented by Gene Hung (San Diego), Holly Kordasiewicz (San Diego), Hien Thuy Zhao (San Diego) and Eric E. Swayze (Encinitas, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present embodiments provide methods, compounds, and compositions useful for inhibiting PMP22 expression and for treating, preventing, or ameliorating a disease associated with PMP22."

The patent was filed on March 8, 2024, under Application No. 18/599,942.

*For further information, including images, charts and tables, pl...